Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy

Abstract : Synthetic alkyl lipids, such as the ether lipids edelfosine (1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine) and ohmline (1-O-hexadecyl-2-O-methyl-rac-glycero-3-β-lactose), are forming a class of antitumor agents that target cell membranes to induce apoptosis and to decrease cell migration/invasion, leading to the inhibition of tumor and metastasis development. In this review, we present the structure-activity relationship of edelfosine and ohmline, and we point out differences and similarities between these two amphiphilic compounds. We also discuss the mechanisms of action of these synthetic alkyl ether lipids (involving, among other structures and molecules, membrane domains, Fas/CD95 death receptor signaling, and ion channels), and highlight a key role for lipid rafts in the underlying process. The reorganization of lipid raft membrane domains induced by these alkyl lipids affects the function of death receptors and ion channels, thus leading to apoptosis and inhibition of cancer cell migration. The possible therapeutic use of these alkyl lipids and the clinical perspectives for these lipids in prevention or/and treatment of tumor development and metastasis are also discussed.
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-01330970
Contributeur : Christophe Vandier <>
Soumis le : lundi 13 juin 2016 - 11:38:04
Dernière modification le : lundi 2 juillet 2018 - 16:20:15

Lien texte intégral

Identifiants

Collections

Citation

Paul-Alain Jaffres, Gajate Consuelo, Ana Bouchet, Hélène Couthon, Aurélie Chantôme, et al.. Alkyl ether lipids, ion channels and lipid raft reorganization in cancer therapy. Pharmacology and Therapeutics, Elsevier, 2016, 〈http://www.sciencedirect.com/science/article/pii/S0163725816300936〉. 〈10.1016/j.pharmthera.2016.06.003〉. 〈inserm-01330970〉

Partager

Métriques

Consultations de la notice

235